Evidence map›Paper›PMID 36094183›Full record

ArticleAntimicrobial agents and chemotherapy2022

Pharmacokinetics of Ascending Doses of Praziquantel in Adults Infected with Opisthorchis felineus in Western Siberia, Russian Federation.

Alexandra Probst, Daniela Hofmann, Olga S Fedorova, Sofia V Mazeina, Tatiana S Sokolova, Ekaterina Golovach, Jennifer Keiser

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Alexandra ProbstSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Daniela HofmannSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Olga S FedorovaSiberian State Medical Universitygrid.412593.8, Tomsk, Russia.
Sofia V MazeinaSiberian State Medical Universitygrid.412593.8, Tomsk, Russia.
Tatiana S SokolovaSiberian State Medical Universitygrid.412593.8, Tomsk, Russia.ORCID 0000-0002-1085-0733
Ekaterina GolovachSiberian State Medical Universitygrid.412593.8, Tomsk, Russia.
Jennifer KeiserSwiss Tropical and Public Health Institute, Allschwil, Switzerland.ORCID 0000-0003-0290-3521
Siberian State Medical University · RUSwiss Tropical and Public Health Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opisthorchiasis due to the liver fluke Opisthorchis felineus is highly prevalent in rural regions of Western Siberia, causing severe liver and bile duct maladies. Praziquantel administered as a three-dose regimen is the only drug used to treat O. felineus-infected individuals. A simpler single-dose treatment might serve as an alternative. The aim of this study was to compare the pharmacokinetic (PK) properties of single, ascending doses of praziquantel compared to multiple dosing in patients infected with O. felineus to contribute to updated treatment guidelines. Dried blood spots (DBSs) of 110 adults were collected at 11 time points post-drug administration at single oral doses of 20, 40, and 60 mg/kg, as well as 3× 20 mg/kg (4 h dosing interval). DBS samples were analyzed using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, and PK parameters were obtained for

Indexed as

AnthelminticsOpisthorchiasisOpisthorchisAdultAnimalsChromatography, LiquidHumansPraziquantelRussiaSiberiaTandem Mass SpectrometryAnthelminticsPraziquantelanthelminticdried blood spotsLC-MS/MSopisthorchiasisOpisthorchis felineuspharmacokineticspraziquantel

Identifiers

PMID36094183
PMCPMC9578388
OpenAlexW4295279927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.